Back to search results

Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis

IsraelRecruitingPHASE3

Conditions

Hepatocellular Carcinoma · Cirrhosis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Site 881, Dallas, Texas, United States

  • 841 University Clinical Centre of Republic of Srpska, Banja Luka, Bosnia and Herzegovina

  • 843 University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina

  • 842 University Clinical Centre Sarajevo, Sarajevo, Bosnia and Herzegovina

  • 831 Dept of Medical Oncology, Complex Oncology Ctr - Burgas EOOD, Burgas, Bulgaria

  • 835 First Department of Medical Oncology, Gastroenterology and Pulmology, Complex Oncology Center - Plovdiv EOOD, Plovdiv, Plovdiv, Bulgaria

  • Medical Center Leo Clinic EOOD Plovdiv, Plovdiv, Bulgaria

  • 834 Medical Oncology Dept, Univ Multiprofile Hospital for Active Treatment "Sv. Ivan Rilski" EAD, Sofia, Sofia, Bulgaria

  • 518 Rabin Medical Center Beilinson Hospital, Petah Tikva, Israel

    Contact: Study coordinator (Salomon Stemmer, MD)

  • 872 IMSP Institute of Oncology, Chisinau, Moldova

  • Site 858, Koszalin, Poland

  • Site 852, Krakow, Poland

  • Site 857, Mysłowice, Poland

  • Site 859, Przemyśl, Poland

  • Site 855, Warsaw, Poland

  • Site 850, Wroclaw, Poland

  • 802 Institutul Regional de Gastroenterologie si Hepatologie, Cluj-Napoca, Romania

  • 807 IOCN, Medical Oncology, Cluj-Napoca, Romania

  • 809 Spitalul Clinic Judetean de Urgenta Constanta Oncology Dept, Constanța, Romania

  • 801 Oncology Center "Sf. Nectarie" Medical Oncology, Craiova, Romania

  • 803 Oncolab SRL, Craiova, Romania

  • 805 Euroclinic lasi, Iași, Romania

  • 810 IRO Iasi-Clinica Oncologie Medicala, Iași, Romania

  • 808 Spitalul Clinic Pelican Oradea Oncology Department, Oradea, Romania

  • 804 Oncomed - Medical Oncology, Timișoara, Romania

  • 806 Oncocenter Oncologie Clinica SRL, Timișoara, Romania

  • 821 Clinic for Gastroenterology and Hepatology, Military Medical Academy, Belgrade, Serbia

  • 822 Oncology Institute of Vojvodina, Kamenitz, Serbia

  • 823 Oncology Department, Health Center Kladovo, Kladovo, Serbia

  • 824 Univ Clin Centre Kragujevac, Dept of Oncology, Kragujevac, Serbia

  • Site 867, Banská Bystrica, Slovakia

  • Site 865, Košice, Slovakia

Study leads

  • Michael H Silverman, MD

    Study Director

    BioStrategics Consulting Ltd

View source on ClinicalTrials.gov(opens in a new tab)Contact study team (email)